Semaglutide could benefit millions of Americans with obesity, heart disease

The anti-obesity drug has the potential to reduce the risk of heart attacks and other heart-related conditions among 6.6 million Americans, a Yale study finds.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news